Immunotherapy for Patients with Follicular Lymphoma: The Contribution of Systematic Reviews

Publisher： Karger

E-ISSN： 1421-9662|125|1-2|23-31

ISSN： 0001-5792

Source： Acta Haematologica, Vol.125, Iss.1-2, 2010-12, pp. : 23-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infections in Hematogical Cancer Patients: The Contribution of Systematic Reviews and Meta-Analyses

By  

Acta Haematologica, Vol. 125, Iss. 1-2, 2010-12 ,pp. : 80-90

Karger

Access to resources Recommend Favorite

A retrospective study on the management of patients with rituximab refractory follicular lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 2, 2018-01 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 193-199

Karger

Access to resources Recommend Favorite

Retreatment with rituximab offers a similar survival benefit as maintenance therapy in patients with low tumor burden follicular lymphoma

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 1, 2015-01 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4129-4136

John Wiley & Sons Inc

Access to resources Recommend Favorite